We help healthcare brands find their way into the GCC
YallaRx is a cross-border commercialization platform across the region. Since 2019, we've combined regulatory expertise, data analytics, and marketing capabilities to deliver efficient, compliant, and profitable market launches for healthcare brands entering the Middle East.
A cross-border commercialization platform, not a one-off vendor
YallaRx was founded in 2019 to close a specific gap: international healthcare brands had strong products, but no reliable route into the GCC's regulatory and distribution landscape. We built that route — as a cross-border commercialization platform combining local regulatory know-how, a growing database of the region's registered medicines, and hands-on commercial execution.
Today our team works daily to scout and expand our database of the world's best manufacturers of demanded generics and innovative molecules, so that every client decision — what to register, where, and through which model — is backed by data rather than guesswork.
What we bring to the table
- ✓ Big Data and AI-powered market intelligence
- ✓ Comprehensive business intelligence & reporting
- ✓ Highly skilled team of international experts
- ✓ Strong relationships with key local distributors
- ✓ Databases spanning 20+ countries, updated daily
The problems brands run into without us
No knowledge of the specifics of the local distribution network.
Lack of understanding of sales volumes and true portfolio potential.
For non-European manufacturers: more stringent dossier requirements.
For European manufacturers: gaps in pharmacovigilance expectations between Europe and the GCC.
Explore new horizons together with YallaRx
Let's build your cross-border success story together.
Email us